We will be at SEMICON JAPAN 2023, from 13 to 15 December in Tokyo.Don't miss the opportunity to meet OPTOI at the Italian Pavilion n.7722, together with many leading companies in the European ICT market!Connect with our team to learn more about our products, technologies and our latest innovations in the semiconductor fieldInnovazione
Visit Optoi at Semicon Japan 2023 - Hall 7 Booth 7722
We will be at SEMICON JAPAN 2023, from 13 to 15 December in Tokyo.Don't miss the opportunity to meet OPTOI at the Italian Pavilion n.7722, together with many leading companies in the European ICT market!Connect with our team to learn more about our products, technologies and our latest innovations in the semiconductor field
Our president Alfredo Maglione, Ambassador of Innovation at the A&T - Automation & Testing Fair
Italian industry is living through a profound transformation. Crucial is the contribution of Additive Manufacturing, valuable for increasing competitiveness and profits in production processes; it is a central issue, not only for companies but for the whole country.It will be discussed on October 27 in Vicenza, Italy, as part of the important A&T - Automation & Testing exhibition. Among the protagonists of the prestigious round table, organized by HIT - Hub Innovazione Trentino, will be our president Alfredo Maglione, who will illustrate the experience of the OPTOI Group and some specificities of the Trentino ecosystem of manufacturing innovation.We look forward to seeing you there from October 25 to 27 ! Link > https://vicenza.aetevent.com/
Visit us at LASER World of PHOTONICS!
Join us at LASER World of PHOTONICS, the world's leading trade show and conference for photonics components, systems and applications attend from June 27th to 30th! This is the place where market leaders and decision makers exchange information on the topics of the future as well as on the latest developments in the photonics sciences. Optoi will exhibit the latest optoelectronics technology, customized Detectors and LEDs, in Munich at Hall A2 Stand 340!
OPTOI has been selected for the IPCEI ME/CT project.
Recently the European Commission has approved under EU State aid rules, an Important Project of Common European Interest (IPCEI) to support research, innovation and the first industrial deployment of microelectronics and communication technologies across the value chain. The project, called “IPCEI ME/CT”, was jointly prepared and notified by fourteen Member States: Austria, Czechia, Finland, France, Germany, Greece, Ireland, Italy, Malta, the Netherlands, Poland, Romania, Slovakia and Spain. The Member States will provide up to €8.1 billion in public funding, which is expected to unlock additional €13.7 billion in private investments. As part of this IPCEI, 56 Direct Partners and 30 Associated Partners, including small and medium-sized enterprises (‘SMEs') and start-ups, will undertake 68 projects. Among them we are pleased to announce the presence of OPTOI, which has been selected among the very few Italian entities as an associate partner. The Commission's approval of this IPCEI is part of the wider Commission efforts to ensure a greener, digital, more secure, resilient, and sovereign European economy, as the OPTOI Group we are ready to play our part in achieving these goals that will lead to important positive spillovers throughout Europe.Info - https://ec.europa.eu/commission/presscorner/detail/en/ip_23_3087
International Convention BIO 2023
From June 5 to 8, we are at the BIO 2023 international conference in Boston with our Biomedical Business Manager Cristina Ress. "Stand up for innovation. Stand up for truth. And stand up for science. It’s time to inspire, honor, and recognize the true value of the breakthrough work biotech performs for society. Today. And every day. Well into the future."To schedule a one-on-one meeting you can access the following link - Request Meeting
Workshop "Non-coding RNAs as emerging biomarkers for human diseases: new insights and analytical strategie".
We are pleased to inform you that the workshop "Non-coding RNAs as emerging biomarkers for human diseases: new insights and analytical strategie" organized by Prof. Michela Denti (UniTrento CIBIO) by colleague Simone Detassis (OPTOI), Biomedical Division Manager , Cristina Ress (OPTOI) and Salvatore Pernagallo (DESTINA Genomics Ltd.) will be held on July 3."The plethora of RNA species in the living world demonstrates that between DNA and proteins the regulation of life has almost unlimited potential. In this workshop, we will try to shed light on recent advances in non-coding RNAs used as biomarkers for human diseases and the difficulty of translating them into the clinic."The registration deadline for the short talk or poster session is June 4.The registration deadline for participation is June 16.For info and registration: https://webapps.unitn.it/form/it/Web/Application/convegni/noncodingrnasHere is the link to the program: https://webmagazine.unitn.it/en/evento/cibio/116703/non-coding-rnas-as-emerging-biomarkers-for-human-diseases
Our CEO Alfredo Maglione at Wired Next Fest 2023
Speaking at the Wired Next Fest 2023 event talk, "Il capitale nel territorio" our president Alfredo Maglione, stressed the importance of a dynamic and vibrant innovation ecosystem where research centers and innovative companies dialogue and work together.President Maglione recalled the relevance of the European Chips Act, which is essential to defend the leadership, autonomy and competitiveness of the European manufacturing industry.Watch the talk video here
SIT acquires stake in UpSens (Optoi Group), an innovative SME developing air quality monitoring sensors.
In the wake of the pandemic, the air quality monitoring and control tools market is expected to see strong growth due to the increasingly central role of home comfort and energy efficiency The market for Controlled Mechanical Ventilation (solutions that ensure healthy air and heat recovery) forecasts that 3 million devices will be installed in Europe by 2026 - tripling therefore the current number SIT takes a 10% stake in UpSens through a dedicated capital increase, in support of development and to expand its range of solutions, in furtherance of the group's mission Padua, January 17, 2023 - SIT, a multinational listed on the Euronext Milan segment of the Italian Stock Exchange which creates intelligent solutions for the control of environmental conditions and consumption measurement, announces the acquisition of a stake in UpSens, an innovative SME based in Trento and belonging to the Optoi Group, specialising in the development of devices for monitoring indoor environmental parameters, both in standard and custom versions, with specific expertise in air quality. The transaction was completed through a share capital increase after which SIT holds a 10% stake in UpSens. Basis of the transaction - The pandemic has brought an awareness that the ongoing monitoring of air quality, noise, and brightness in indoor environments, as well as the automated control of the systems involved in their management (air conditioning, heating, and ventilation), are a basic requirement for people's health. A focus upon health and well-being in indoor environments is growing: in Italy and other industrialised countries, people spend about 90% of their time indoors, where the air can be as much as 5 times more polluted than outdoors. Smart buildings have therefore grown in popularity over recent years, involving the digital and automated connection, thanks to IoT and home automation, of residential and office buildings, which therefore become “intelligent”, capable of monitoring quality parameters and managing in an automated way the systems that make an indoor space healthy. Major synergies will arise from the collaboration between SIT and UpSens in the area of air quality solutions, particularly in the CMV (Controlled Mechanical Ventilation) segment. VMC solutions enable air exchange and filtration and, through heat exchange between the outgoing and incoming air, improve the thermal efficiency of buildings. SIT is already a supplier of control electronics for the CMV segment and plans to further expand its range over the coming years. The partnership with UpSens is part of this strategic development path for the segment. CMV, IoT and smart building: market context - The market for CMV (Controlled Mechanical Ventilation) systems is expected to grow strongly over the coming years; in fact, about 3 million systems are expected to be installed in Europe in 2026, therefore approximately tripling the current number. In the IoT sector, technology solutions capable of curbing energy consumption are also seeing increasing development - given that monitoring energy consumption is the second largest area of focus for smart building start-ups. In the US, start-ups in the "IoT for smart building" sector raised 44% of total funding for the start-ups examined by the Smart Building & City Report of the Internet of Things and Start-up Intelligence Research Centres of the Milan Polytechnic. In Italy in 2021, the IoT market was worth Euro 7.3 billion (+22% on 2020), with growth well above that of the digital market as a whole. McKinsey estimates that by 2030, the potential economic value of the global IoT industry could range from $5,000+ to $12 trillion, including at least $440 billion in the domestic sphere. "Indoor air quality control has been central to SIT's mission since before the pandemic. This is something that greatly affects quality of life, as people are realizing now more than ever” stated Federico de' Stefani, Chairperson and CEO of SIT, "This awareness has driven investments, also thanks to government bonuses, in air purification solutions on the one hand and energy efficiency on the other, in order not to waste the heat generated, which is so expensive today. In order to tap into opportunities in this market segment," de' Stefani continued, "we have found in UpSens a competent partner who shares our mission. We want to play a leading role in the energy transition, creating solutions that can truly make a difference in all of our lives and that are in line with decarbonisation goals and environmental protection policies." "Sensors and innovative technologies for measuring air quality in the environments in which we live have become increasingly important over recent years. This vision, strengthened by our awareness of wellness and health, together with our focus on sustainability, was behind the creation of UpSens" stated Alfredo Maglione, Chairperson of UpSens and the Optoi Group. "The corporate partnership with a group like SIT is a great honour. I am sure that the new partnership will be of mutual benefit to both companies and allow them to grow in the areas of environmental monitoring - and particularly in air quality systems through Controlled Mechanical Ventilation systems. The market increasingly requires sensors for these applications also" Maglione continued, "and UpSens can rely on the Optoi Group's ability to develop and produce sensors in-house”.
Optoi at MEDICA - booth Hall 15/J32-5
We exhibits at MEDICA, 14-17 November, Düsseldorf.Don't miss the opportunity to meet us at MEDICA, the world’s largest event for the medical sector!Get in touch with our team to discover more about our products, technologies and our latest innovations for integrated solutions in biotech field, healthcare and pharma.Visit us at the OPTOI group booth Hall 15/J32-5!